← Evidence map

ArticleFrontiers in pharmacology2024

Discovery of novel PARP1/NRP1 dual-targeting inhibitors with strong antitumor potency.

Juanjuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39679370